Satvat Ali J.

CIK 00016217884 companiesMENLO PARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001621788

Recent Transactions

50 trades

Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2026-06-22+5,277→ 5,277 total
Award
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-06-22+3,990→ 169,983 total
Award
Coherus Oncology, Inc.$CHRS
Common Stock
2026-06-05+30,000→ 30,000 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2026-06-05+60,000→ 60,000 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2025-06-20+8,425→ 8,425 total
Award
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-06-20+6,589→ 165,993 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2025-06-12+112,000→ 112,000 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2024-12-30−39,851→ 0 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2024-12-30−79,702→ 0 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2024-12-30$10.99/sh+79,702→ 79,702 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2024-12-30$26.21/sh+39,851→ 159,404 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2024-12-30−39,851→ 0 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2024-12-30$16.68/sh+39,851→ 119,553 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2024-06-21+26,014→ 26,014 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (right to buy)
2023-06-21+51,501→ 51,501 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (right to buy)
2022-06-22+104,921→ 104,921 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (right to buy)
2021-06-17+38,895→ 38,895 total
Disposition to Issuer
Eidos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-01-26−43,056→ 0 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2021-01-26+39,851→ 39,851 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2021-01-26+79,702→ 79,702 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2021-01-26+39,851→ 39,851 total
Disposition to Issuer
Eidos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-01-26−21,528→ 0 total
Disposition to Issuer
Eidos Therapeutics, Inc.
Stock Option (Right to Buy)
2021-01-26−21,528→ 0 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (right to buy)
2020-06-02+112,422→ 112,422 total
Award
Eidos Therapeutics, Inc.
Stock Option (right to buy)
2020-05-27+21,528→ 21,528 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2020-01-10+20,000→ 20,000 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (right to buy)
2019-12-12+82,878→ 82,878 total
Purchase
Eidos Therapeutics, Inc.
Common Stock
2019-07-03$29.90/sh+882,353→ 24,575,501 total
Award
Eidos Therapeutics, Inc.
Stock Option (right to buy)
2019-06-12+21,528→ 21,528 total
Purchase
Eidos Therapeutics, Inc.
Common Stock
2019-05-24$25.93/sh+1,103,848→ 23,693,148 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2019-01-11+20,000→ 20,000 total
Purchase
Eidos Therapeutics, Inc.
Common Stock
2018-12-10$13.29/sh+37,989→ 22,586,636 total
Purchase
Eidos Therapeutics, Inc.
Common Stock
2018-12-10$13.96/sh+2,664→ 22,589,300 total
Purchase
Eidos Therapeutics, Inc.
Common Stock
2018-12-07$14.36/sh+4,860→ 22,548,647 total
Purchase
Eidos Therapeutics, Inc.
Common Stock
2018-12-07$13.94/sh+36,314→ 22,543,787 total
Purchase
Eidos Therapeutics, Inc.
Common Stock
2018-12-06$13.34/sh+38,970→ 22,507,473 total
Purchase
Eidos Therapeutics, Inc.
Common Stock
2018-12-05$14.01/sh+1,103,848→ 22,468,503 total
Purchase
Eidos Therapeutics, Inc.
Common Stock
2018-12-03$15.50/sh+1,750,000→ 21,364,655 total
Award
Eidos Therapeutics, Inc.
Stock Option (right to buy)
2018-07-01+43,056→ 43,056 total
Exercise of In-Money
Eidos Therapeutics, Inc.
Warrants
2018-06-22−332,262→ 0 total
Conversion
Eidos Therapeutics, Inc.
Series B Convertible Preferred Stock
2018-06-22−2,909,029→ 0 total
Exercise of In-Money
Eidos Therapeutics, Inc.
Series B Convertible Preferred Stock
2018-06-22+332,262→ 2,909,029 total
Conversion
Eidos Therapeutics, Inc.
Common Stock
2018-06-22+18,826,417→ 18,826,417 total
Purchase
Eidos Therapeutics, Inc.
Common Stock
2018-06-22$17.00/sh+1,000,000→ 19,614,655 total
Conversion
Eidos Therapeutics, Inc.
Series Seed Preferred Stock
2018-06-22−12,832,123→ 0 total
Tax Payment
Eidos Therapeutics, Inc.
Common Stock
2018-06-22$17.00/sh−211,762→ 18,614,655 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2018-02-01+20,000→ 20,000 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2017-05-17+20,000→ 20,000 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2016-05-24+10,000→ 10,000 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2015-04-01+20,000→ 20,000 total

Companies

Recent Filings

Address

C/O KOHLBERG KRAVIS ROBERTS & CO. L.P. 2800 SAND HILL ROAD

MENLO PARK, CA, 94025

View on SEC.gov